Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

SPDR® S&P Biotech ETF (XBI)

Delayed Data
As of Jan 13
 +0.52 / +0.81%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.


1 month+6.91% 3 years+9.79%
3 months+6.10% 5 years+22.06%
1 year+19.29% Since inception+13.75%
Data through 01/14/2017

Quote Details

Previous close$64.48
Open day’s range64.36 – 65.79
Net asset value (NAV)65.07 (01/13/2017)
Daily volume6,715,501
Average volume (3 months)6,646,232
Data as of 01/13/2017

Peer Comparisonvs. Health ETFs

Performance 5-yr return+22.06%+16.84%
Expense Gross exp ratio0.35%1.32%
Risk 5 year sharpe ratio0.801.08
Net assets$2.5B$2.8B
Average market cap$4.1B$29.6B
Average P/E--18.1
Dividend / Share--0.32%


XLV Health Care Select Sector SPDR® Fund
FHLC Fidelity® MSCI Health Care Index ETF
RYH Guggenheim S&P 500® Equal Weight Health...


Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
CLVS Clovis Oncology Inc2.83%
UTHR United Therapeutics Corp2.53%
ACAD ACADIA Pharmaceuticals Inc2.50%
IONS Ionis Pharmaceuticals Inc2.44%
ICPT Intercept Pharmaceuticals Inc2.38%
CELG Celgene2.37%
AMGN Amgen2.37%
ABBV AbbVie2.36%
BMRN Biomarin Pharmaceutical Inc2.33%